PharmaTher Holdings Ltd News

Express News | Pharmather Holdings Ltd - Generic Drug User Fee Amendments of 2022 Goal Date of October 29, 2024

ReutersMay 10 08:00 ET

Express News | Pharmather Holdings Ltd - Receipt of Amendment Acknowledgment Letter for Its Priority Original Abbreviated New Drug Application for Ketamine

ReutersMay 10 07:59 ET

Express News | Pharmather Holdings Ltd - Receipt of a Complete Response Letter ("Crl") for Its Priority Original Abbreviated New Drug Application for Ketamine

Moomoo 24/7Apr 18 16:00 ET

Express News | Pharmather Holdings Ltd: Has Completed Necessary Tests and Responses to Address Fda's Comments

Moomoo 24/7Apr 18 16:00 ET

PharmaTher Updated on Its Priority Original Abbreviated New Drug Application for Ketamine

MT NewswiresApr 16 08:39 ET

PharmaTher Provides Update on Its Priority Original Abbreviated New Drug Application For Ketamine

MT NewswiresFeb 12 08:43 ET

PharmaTher Provided Update for Expected FDA Approval of Ketamine

MT NewswiresJan 10 08:08 ET

PharmaTher Brief: Submitting Priority Original Abbreviated New Drug Application for KETARX (Ketamine) to FDA

MT NewswiresSep 6, 2023 07:34 ET

PharmaDrug Announces $300,000 Strategic Investment in Sairiyo Subsidiary by PharmaTher

InvestingJul 18, 2023 08:33 ET

Express News | PharmaTher Brief: Announcing "Positive" Research Results for PharmaPatch With N,N-dimethyltryptamine (DMT) and Strategic Investment Into Sairiyo Therapeutics

Moomoo 24/7Jul 18, 2023 07:35 ET

Analysts Offer Insights on Healthcare Companies: PharmaTher Holdings Ltd (OtherPHRRF), Rezolute (RZLT) and ADC Therapeutics (ADCT)

TipRanksSep 19, 2022 06:40 ET